Teva Pharmaceutical Industries (TEVA +6.6%) is up on more than triple normal volume, but has retraced 10% from its intraday high of $8.95 on reports that plaintiff attorneys are “not on board” with its announced global settlement framework.
https://seekingalpha.com/news/3507423-teva-highs-conflicting-opinions-broad-opioid-settlement
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.